InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.250
-0.130 (-9.42%)
At close: Oct 13, 2025, 4:00 PM EDT
1.290
+0.040 (3.20%)
After-hours: Oct 13, 2025, 7:57 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $84.68 million as of October 13, 2025. Its market cap has decreased by -5.38% in one year.
Market Cap
84.68M
Enterprise Value
29.02M
1-Year Change
-5.38%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $84.68M, a decrease of -75.90%. That is a compound annual growth rate of -16.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 93.49M | -35.72% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | 141.99M | 37.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |